In Silico Evaluation of Ligand Interaction with Nrf2, V1a Receptor, SOD, and Angiotensin II: A Molecular Docking Study
International Journal of Drug Delivery Technology · 04.04.2026 · 16 (5s)
DOI: 10.25258/ijddt.16.5s.53 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 04.04.2026. Verfasst von Reddy Prasad C und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Oxidative stress, inflammation, apoptosis, and vascular dysregulation play crucial roles in the development of chronic diseases such as cancer, cardiovascular disorders, and metabolic syndromes. Targeting regulatory proteins involved in these pathways using natural bioactive compounds has emerged as a promising therapeutic strategy. Molecular docking provides a computational approach to predict ligand–protein interactions and identify potential molecular targets.
Aim
To evaluate the binding affinity and interaction profile of the selected ligand against key regulatory proteins involved in oxidative stress and vascular signalling pathways.
Methods
Molecular docking analysis was performed to assess the interaction of Punicalligin with apoptotic and metastatic regulatory proteins, including V1a, Superoxide dismutase (SOD), NrF2, and Angiotensin II. Protein crystal structures were retrieved from the Protein Data Bank. Docking was conducted using Auto Dock 1.5.4 with the Lamarckian Genetic Algorithm (100 runs), applying a grid box of 90 Å × 90 Å × 90 Å and 0.45 Å spacing. Docked complexes were visualized using BIOVIA Discovery Studio.
Results
The Punicalligin exhibited favourable binding with all targets, reflected by negative binding energy values. Nrf2 showed the strongest binding affinity (–10.9 kcal/mol), followed by the V1a receptor (–9.6 kcal/mol), Angiotensin II (– 8.5 kcal/mol), and SOD (–8.0 kcal/mol). Nrf2 and V1a formed five hydrogen bonds each, with additional π interactions enhancing complex stability.
Conclusion
Punicalligin demonstrated that the highest binding preference toward Nrf2, and V1a Receptors suggesting it as a promising molecular target for further experimental validation and molecular dynamics investigations
Zitieren
APA
C, R. P., D, S. R., Mudhol, M. B., K, A. K. A., Jayaraman, S., & Jayaraman, T. (2026). In Silico Evaluation of Ligand Interaction with Nrf2, V1a Receptor, SOD, and Angiotensin II: A Molecular Docking Study. International Journal of Drug Delivery Technology, 16(5s). https://doi.org/10.25258/ijddt.16.5s.53
Vancouver
C RP, D SR, Mudhol MB, K AKA, Jayaraman S, Jayaraman T. In Silico Evaluation of Ligand Interaction with Nrf2, V1a Receptor, SOD, and Angiotensin II: A Molecular Docking Study. International Journal of Drug Delivery Technology. 2026;16(5s). doi:10.25258/ijddt.16.5s.53
BibTeX
@article{C2026,
author = {C, Reddy Prasad and D, Santoshi Roopa and Mudhol, Mahesh Basanagauda and K, Afzal Khan A and Jayaraman, Selvaraj and Jayaraman, Thirunavukkarasu},
title = {In Silico Evaluation of Ligand Interaction with Nrf2, V1a Receptor, SOD, and Angiotensin II: A Molecular Docking Study},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {5s},
doi = {10.25258/ijddt.16.5s.53}
}
EUVIMED